SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Q122’s year-over-year growth in the WW Spine market shows normalized, nominal growth for this quarter, w...
Adam Hattan, VP of Marketing for Route 92 Medical, discusses the Company, its novel system for mechanica...
Although revenues still show signs of COVID-19 impact, robotic procedures and implant pull-through accel...
Could biosensors and smart dressings be the final frontier in wound diagnostics? SmartTRAK explores the ...
Despite mixed results from Trauma players, the segment experienced healthy growth as mergers and acquisi...
Emerging from the COVID-19 era, wound care innovation is driven by small players, especially in the digi...
Improved aspiration systems, large-bore catheters, balloon-guide catheters and radial access top the lis...
Imagine if you could… See gaps in your product portfolio vs your competitors’ Discover your next acquisi...
Q122 started slow but ended on a bright note as COVID-19 concerns faded and surgical volumes approached ...
Wallaby Medical CEO and founder Michael Alper discusses the Company’s recent acquisition of phenox GmBH ...
Login